References
1.
Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–41.
2.
Mirahmadi MK, Byrne C, Barton C, Penera N, Gordon S, Vaziri ND: Prediction of creatinine clearance from serum creatinine in spinal cord injury patients. Paraplegia 1983;21:23–29.
3.
Cocchetto DM, Tschanz C, Bjornsson TD: Decreased rate of creatinine production in patients with hepatic disease: Implications for estimation of creatinine clearance. Ther Drug Monit 1983;5:161–168.
4.
Delanghe JR, Louagie HK, De Buyzere ML, Leroux-Roels GG: Glomerular filtration rate and creatinine production in adult icteric patients. Clin Chim Acta 1994;224:33–44.
5.
Spencer K: Analytical reviews in clinical biochemistry: The estimation of creatinine. Ann Clin Biochem 1986;23:1–25.
6.
Mayersohn M, Conrad KA, Achari R: The influence of a cooked meat meal on creatinine plasma concentration and creatinine clearance. Br J Clin Pharmacol 1983;15:227–230.
7.
Gates GF: Creatinine clearance estimation from serum creatinine values: An analysis of three mathematical models of glomerular function. Am J Kidney Dis 1985;5:199–205.
8.
Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985;28:830–838.
9.
Meyer TW, Baboolal K, Brenner BM: Nephron adaptations to renal injury; in Brenner BM (ed): Brenner and Rector’s the Kidney. Philadelphia, Saunders, 1996, pp 2011–2014.
10.
Jones JD, Burnett PC: Creatinine metabolism in humans with decreased renal function: Creatinine deficit. Clin Chem 1974;20:1204–1212.
11.
Mitch WE, Collier VU, Walser M: Creatinine metabolism in chronic renal failure. Clin Sci 1980;58:327–335.
12.
Hankins DA, Babb AL, Uvelli DA, Scribner BH: Creatinine degradation I: The kinetics of creatinine removal in patients with chronic kidney disease. Int J Artif Organs 1981;4:35–39.
13.
Jaffé M: Über den Niederschlag, welchen Pikrinsäure in normalem Harn erzeugt und über eine neue Reaction des Kreatinins. Z Physiol Chem 1886;10:391–400.
14.
Cook JGH: Technical Bulletin No 36. Factors influencing the assay of creatinine. Ann Clin Biochem 1975;12:219–232.
15.
Levey AS, Perrone RD, Madias NE: Serum creatinine and renal function. Annu Rev Med 1988;39:465–490.
16.
Weber JA, van Zanten AP: Interferences in current methods for measurements of creatinine. Clin Chem 1991;37:695–700.
17.
Gerard SK, Khayam-Bashi H: Characterization of creatinine error in ketotic patients. A prospective comparison of alkaline picrate methods with an enzymatic method. Am J Clin Pathol 1985;84:659–664.
18.
Kemperman FA, Weber JA, Gorgels J, van Zanten AP, Krediet RT, Arisz L: The influence of ketoacids on plasma creatinine assays in diabetic ketoacidosis. J Intern Med 2000;248:511–517.
19.
Rosano TG, Ambrose RT, Wu AH, Swift TA, Yadegari P: Candidate reference method for determining creatinine in serum: Method development and interlaboratory validation. Clin Chem 1990;36:1951–1955.
20.
Zwang L, Blijenberg BG: Assessment of a selected method for creatinine with special emphasis on bilirubin interference. Eur J Clin Chem Clin Biochem 1991;29:795–800.
21.
Kemperman FA, Silberbusch J, Slaats EH, van Zanten AP, Weber JA, Krediet RT, Arisz L: Glomerular filtration rate estimation from plasma creatinine after inhibition of tubular secretion: Relevance of the creatinine assay. Nephrol Dial Transplant 1999;14:1247–1251.
22.
Blijenberg BG, Liesting EC, Zwang L: Creatinine and automatic analysers in relation to icteric specimens. Eur J Clin Chem Clin Biochem 1992;30:779–784.
23.
Popper H, Mandel E: Filtrations- und Reabsorptionsleistung in der Nierenpathologie. Ergeb Inn Med Kinderheilkd 1937;53:685–694.
24.
Rosano TG, Brown HH: Analytical and biological variability of serum creatinine and creatinine clearance: Implications for clinical interpretation. Clin Chem 1982;28:2330–2331.
25.
Brochner-Mortensen J: Current status on assessment and measurement of glomerular filtration rate. Clin Physiol 1985;5:1–17.
26.
Payne RB: Creatinine clearance: A redundant clinical investigation. Ann Clin Biochem 1986;23:243–250.
27.
Adam W: All that is excreted does not glister: Or why do we keep on collecting urine to measure creatinine clearance? Aust NZ J Med 1993;23:638.
28.
Walser M: Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis 1998;32:23–31.
29.
Perrone RD, Madias NE, Levey AS: Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 1992;38:1933–1953.
30.
Bauer JH, Brooks CS, Burch RN: Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 1982;2:337–346.
31.
Miller BF, Winkler AW: The renal excretion of endogenous creatinine in man, comparison with exogenous creatinine and inulin. J Clin Invest 1938;17:31–40.
32.
Van Acker BA, Koomen GC, Koopman MG, de Waart DR, Arisz L: Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 1992;340:1326–1329.
33.
Toto RD: Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance. Curr Opin Nephrol Hypertens 1995;4:505–509.
34.
Giovannetti S, Barsotti G: In defense of creatinine clearance. Nephron 1991;59:11–14.
35.
Miller BF, Leaf A, Mamby AR, Miller R: Validity of endogenous creatinine clearance as a measure of glomerular filtration rate in the diseased human kidney. J Clin Invest 1952;31:309–313.
36.
Sjostrom PA, Odlind BG, Wolgast M: Extensive tubular secretion and reabsorption of creatinine in humans. Scand J Urol Nephrol 1988;22:129–131.
37.
Burry HC, Dieppe PA: Apparent reduction of endogenous creatinine clearance by salicylate treatment. Br Med J 1976;ii:16–17.
38.
Dubb JW, Stote RM, Familiar RG, Lee K, Alexander F: Effect of cimetidine on renal function in normal man. Clin Pharmacol Ther 1978;24:76–83.
39.
Ducharme MP, Smythe M, Strohs G: Drug-induced alterations in serum creatinine concentrations. Ann Pharmacother 1993;27:622–633.
40.
Shannon JA: The renal excretion of creatinine in man. J Clin Invest 1935;14:403–410.
41.
Burgess E, Blair A, Krichman K, Cutler RE: Inhibition of renal creatinine secretion by cimetidine in humans. Renal Physiol 1982;5:27–30.
42.
Kasiske BL, Keane WF: Laboratory assessment of renal disease: Clearance, urinalysis and renal biopsy; in Brenner BM (ed): Brenner and Rector’s the Kidney. Philadelphia, Saunders, 1996, pp 1142–1143.
43.
Gisclon LG, Giacomini KM: Inhibition of cimetidine transport by creatinine in luminal membrane vesicles prepared from rabbit kidney. Drug Metab Dispos 1988;16:331–332.
44.
Van Ginneken CA, Russel FG: Saturable pharmacokinetics in the renal excretion of drugs. Clin Pharmacokinet 1989;16:38–54.
45.
Abraham PA, Opsahl JA, Halstenson CE, Chremos AN, Matzke GR, Keane WF: The effect of famotidine on renal function in patients with renal insufficiency. Br J Clin Pharmacol 1987;24:385–389.
46.
Van den Berg JG, Koopman MG, Arisz L: Ranitidine has no influence on tubular creatinine secretion. Nephron 1996;74:705–708.
47.
Andreev E, Koopman M, Arisz L: A rise in plasma creatinine that is not a sign of renal failure: Which drugs can be responsible? J Intern Med 1999;246:247–252.
48.
Cahen R, Martin A, Francois B, Baltassat P, Louisot P: Creatinine metabolism impairment by an anticonvulsant drug, phenacemide. Ann Pharmacother 1994;28:49–51.
49.
Edwards KDG, Whyte HM: Plasma creatinine level and creatinine clearance as tests of renal function. Aust Ann Med 1959;8:218–224.
50.
Jelliffe RW: Estimation of creatinine clearance when urine cannot be collected. Lancet 1971;1:975–976.
51.
Jelliffe RW: Creatinine clearance: Bedside estimate (letter). Ann Intern Med 1973;79:604–605.
52.
Mawer GE, Lucas SB, Knowles BR, Stirland RM: Computer-assisted prescribing of kanamycin for patients with renal insufficiency. Lancet 1972;1:12–15.
53.
Bjornsson TD: Use of serum creatinine concentrations to determine renal function. Clin Pharmacokinet 1979;4:200–222.
54.
Hull JH, Hak LJ, Koch GG, Wargin WA, Chi SL, Mattocks AM: Influence of range of renal function and liver disease on predictability of creatinine clearance. Clin Pharmacol Ther 1981;29:516–521.
55.
Salazar DE, Corcoran GB: Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med 1988;84:1053–1060.
56.
Siersbaek-Nielsen K, Hansen JM, Kampmann J, Kristensen M: Rapid evaluation of creatinine clearance. Lancet 1971;1:1133–1134.
57.
Bjornsson TD, Cocchetto DM, McGowan FX, Verghese CP, Sedor F: Nomogram for estimating creatinine clearance. Clin Pharmacokinet 1983;8:365–369.
58.
Lott RS, Uden DL, Wargin WA, Strate RG, Zaske DE: Correlation of predicted versus measured creatinine clearance values in burn patients. Am J Hosp Pharm 1978;35:717–720.
59.
Robinson BA, Frampton CM, Colls BM, Atkinson CH, Fitzharris BM: Comparison of methods of assessment of renal function in patients with cancer treated with cisplatin, carboplatin or methotrexate. Aust NZ J Med 1990;20:657–662.
60.
Cronberg S, Nordstrom L, Ringberg H: Prediction of creatinine clearance by several methods in patients with severe infections. Eur J Clin Pharmacol 1992;42:193–195.
61.
Davis GA, Chandler MH: Comparison of creatinine clearance estimation methods in patients with trauma. Am J Hosp Pharm 1996;53:1028–1032.
62.
Thakur V, Reisin E, Solomonow M, Baratta R, Aguilar E, Best R, D’Ambrosia R, Solanky T: Accuracy of formula-derived creatinine clearance in paraplegic subjects. Clin Nephrol 1997;47:237–242.
63.
Jelliffe RW, Jelliffe SM: Estimation of creatinine clearance from changing serum-creatinine levels. Lancet 1971;ii:710
64.
Hallynck T, Soep HH, Thomis J, Boelaert J, Daneels R, Fillastre JP, De Rosa F, Rubinstein E, Hatala M, Spousta J, Dettli L: Prediction of creatinine clearance from serum creatinine concentration based on lean body mass. Clin Pharmacol Ther 1981;30:414–421.
65.
Goldberg TH, Finkelstein MS: Difficulties in estimating glomerular filtration rate in the elderly. Arch Intern Med 1987;147:1430–1433.
66.
Huang E, Hewitt RG, Shelton M, Morse GD: Comparison of measured and estimated creatinine clearance in patients with advanced HIV disease. Pharmacotherapy 1996;16:222–229.
67.
Robertshaw M, Lai KN, Swaminathan R: Prediction of creatinine clearance from plasma creatinine: Comparison of five formulae. Br J Clin Pharmacol 1989;28:275–280.
68.
Spinler SA, Nawarskas JJ, Boyce EG, Connors JE, Charland SL, Goldfarb S: Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Iohexol Cooperative Study Group. Ann Pharmacother 1998;32:1275–1283.
69.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461–470.
70.
Nguyen HT, Shannon AG, Coates PA, Owens DR: Estimation of glomerular filtration rate in type II (non-insulin dependent) diabetes mellitus patients. IMA J Math Appl Med Biol 1997;14:151–160.
71.
Toto RD, Kirk KA, Coresh J, Jones C, Appel L, Wright J, Campese V, Olutade B, Agodoa L: Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: Results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. J Am Soc Nephrol 1997;8:279–287.
72.
Walser M, Drew HH, Guldan JL: Prediction of glomerular filtration rate from serum creatinine concentration in advanced chronic renal failure. Kidney Int 1993;44:1145–1148.
73.
Nankivell BJ, Gruenewald SM, Allen RD, Chapman JR: Predicting glomerular filtration rate after kidney transplantation. Transplantation 1995;59:1683–1689.
74.
Nankivell BJ, Chapman JR, Allen RD: Predicting glomerular filtration rate after simultaneous pancreas and kidney transplantation. Clin Transplant 1995;9:129–134.
75.
Baracskay D, Jarjoura D, Cugino A, Blend D, Rutecki GW, Whittier FC: Geriatric renal function: Estimating glomerular filtration in an ambulatory elderly population. Clin Nephrol 1997;47:222–228.
76.
Agarwal R, Nicar MJ: A comparative analysis of formulas to predict creatinine clearance (abstract). J Am Soc Nephrol 1994;5:386–386.
77.
Sheiner LB, Beal SL: Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981;9:503–512.
78.
Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307–310.
79.
Coresh J, Toto RD, Kirk KA, Whelton PK, Massry S, Jones C, Agodoa L, van Lente F: Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study. Am J Kidney Dis 1998;32:32–42.
80.
Ixkes MC, Koopman MG, van Acker BA, Weber JA, Arisz L: Cimetidine improves GFR-estimation by the Cockcroft and Gault formula. Clin Nephrol 1997;47:229–236.
81.
Kemperman FA, Silberbusch J, Slaats EH, Prins AM, Weber JA, Krediet RT, Arisz L: Estimation of the glomerular filtration rate in NIDDM patients from plasma creatinine concentration after cimetidine administration. Diabetes Care 1998;21:216–220.
82.
Lemann J, Bidani AK, Bain RP, Lewis EJ, Rohde RD: Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy. Am J Kidney Dis 1990;16:236–243.
83.
Orlando R, Floreani M, Padrini R, Palatini P: Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis. Clin Nephrol 1999;51:341–347.
84.
Rolin HA, Hall PM, Wei R: Inaccuracy of estimated creatinine clearance for prediction of iothalamate glomerular filtration rate. Am J Kidney Dis 1984;4:48–54.
85.
Lindegaard MW, Aass N, Bue ES, Theodorsen L, Fossa SD: Glomerular filtration rate, 131I-hippuran clearance and estimated creatinine clearance in cancer patients. Br J Cancer 1991;64:401–405.
86.
Nicoll SR, Sainsbury R, Bailey RR, King A, Frampton C, Elliot JR, Turner JG: Assessment of creatinine clearance in healthy subjects over 65 years of age. Nephron 1991;59:621–625.
87.
Waller DG, Fleming JS, Ramsey B, Gray J: The accuracy of creatinine clearance with and without urine collection as a measure of glomerular filtration rate. Postgrad Med J 1991;67:42–46.
88.
Waller DG, Juer L, Fleming JS: Measurement of glomerular function during cisplatin therapy. Br J Clin Pharmacol 1991;31:271–274.
89.
Gault MH, Longerich LL, Harnett JD, Wesolowski C: Predicting glomerular function from adjusted serum creatinine. Nephron 1992;62:249–256.
90.
Sampson MJ, Drury PL: Accurate estimation of glomerular filtration rate in diabetic nephropathy from age, body weight, and serum creatinine. Diabetes Care 1992;15:609–612.
91.
Rossing P, Astrup AS, Smidt UM, Parving HH: Monitoring kidney function in diabetic nephropathy. Diabetologia 1994;37:708–712.
92.
Brown SC, O’Reilly PH: Glomerular filtration rate measurement: A neglected test in urological practice. Br J Urol 1995;75:296–300.
93.
Butterworth PC, Harris KP, Nicholson ML: Comparison of glomerular filtration rate and serum creatinine in renal transplant patients. Transplant Proc 1997;29:2776–2777.
94.
Goerdt PJ, Heim-Duthoy KL, Macres M, Swan SK: Predictive performance of renal function estimate equations in renal allografts. Br J Clin Pharmacol 1997;44:261–265.
95.
Roubenoff R, Drew H, Moyer M, Petri M, Whiting-O’Keefe Q, Hellmann DB: Oral cimetidine improves the accuracy and precision of creatinine clearance in lupus nephritis. Ann Intern Med 1990;113:501–506.
96.
DeSanto NG, Coppola S, Anastasio P, Coscarella G, Capasso G, Bellini L, Santangelo R, Massimo L, Siciliano A: Predicted creatinine clearance to assess glomerular filtration rate in chronic renal disease in humans. Am J Nephrol 1991;11:181–185.
97.
Florijn KW, Barendrecht JNM, van Saase JLCM, van Es LA, Chang PC. Reproducibility and accuracy of creatinine clearances during oral cimetidine treatment; in Florijn KW: Thesis, Leiden, 1996, pp 125–145.
98.
Martin L, Chatelut E, Boneu A, Rostaing L, Roussilhes C, Caselles O, Canal P: Improvement of the Cockcroft-Gault equation for predicting glomerular filtration in cancer patients. Bull Cancer 1998;85:631–636.
99.
Schuck O, Teplan V, Vitko S, Matl J, Skibova J, Stollova M: Predicting glomerular function from adjusted serum creatinine in renal transplant patients. Int J Clin Pharmacol Ther 1997;35:33–37.
100.
Luke DR, Halstenson CE, Opsahl JA, Matzke GR: Validity of creatinine clearance estimates in the assessment of renal function. Clin Pharmacol Ther 1990;48:503–508.
101.
Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi A, Alberino F, Gatta A: Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 1994;154:201–205.
102.
De Santo NG, Anastasio P, Cirillo M, Santoro D, Spitali L, Mansi L, Celentano L, Capodicasa D, Cirillo E, Del Vecchio E, Pascale C, Capasso G: Measurement of glomerular filtration rate by the 99mTc-DTPA renogram is less precise than measured and predicted creatinine clearance. Nephron 1999;81:136–140.
103.
Cochran M, St John A: A comparison between estimates of GFR using [99mTc]DTPA clearance and the approximation of Cockcroft and Gault. Aust NZ J Med 1993;23:494–497.
104.
Gross JL, Silveiro SP, de Azevedo MJ, Pecis M, Friedman R: Estimated creatinine clearance is not an accurate index of glomerular filtration rate in normoalbuminuric diabetic patients. Diabetes Care 1993;16:407–408.
105.
Groth S, Aasted M, Vestergaard B: Screening of kidney function by plasma creatinine and single-sample 51Cr-EDTA clearance determination – A comparison. Scand J Clin Lab Invest 1989;49:707–710.
106.
Charleson HA, Bailey RR, Stewart A: Quick prediction of creatinine clearance without the necessity of urine collection. NZ Med J 1980;92:425–426.
107.
Smith SA: Estimation of glomerular filtration rate from the serum creatinine concentration. Postgrad Med J 1988;64:204–208.
108.
Sinton TJ, De Leacy EA, Cowley DM: Comparison of 51Cr EDTA clearance with formulae in the measurement of glomerular filtration rate. Pathology 1986;18:445–447.
109.
Rodby RA, Ali A, Rohde RD, Lewis EJ: Renal scanning 99mTc diethylene-triamine pentaacetic acid glomerular filtration rate (GFR) determination compared with iothalamate clearance GFR in diabetics. The Collaborative Study Group for the Study of Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy. Am J Kidney Dis 1992;20:569–573.
110.
Goral S, Ynares C, Shyr Y, Yeoh TK, Johnson HK: Long-term renal function in heart transplant recipients receiving cyclosporine therapy. J Heart Lung Transplant 1997;16:1106–1112.
111.
McElduff A, Shuter B, Cooper R, Davies L, Fulcher G, Hoschl R, Wilmshurst E: Measuring renal function in patients with diabetes mellitus. J Diabetes Complications 1997;11:225–229.
112.
Fliser D, Bischoff I, Hanses A, Block S, Joest M, Ritz E, Mutschler E: Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged. Eur J Clin Pharmacol 1999;55:205–211.
113.
Zarowitz BJ, Robert S, Peterson EL: Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients. Ann Pharmacother 1992;26:1205–1210.
114.
Wharton WW, Sondeen JL, McBiles M, Gradwohl SE, Wade CE, Ciceri DP, Lehmann HG, Stotler RE, Henderson TR, Whitaker WR: Measurement of glomerular filtration rate in ICU patients using 99mTc-DTPA and inulin. Kidney Int 1992;42:174–178.
115.
Robert S, Zarowitz BJ, Peterson EL, Dumler F: Predictability of creatinine clearance estimates in critically ill patients. Crit Care Med 1993;21:1487–1495.
116.
Goldwasser P, Aboul-Magd A, Maru M: Race and creatinine excretion in chronic renal insufficiency. Am J Kidney Dis 1997;30:16–22.
117.
Obrador GT, Arora P, Kausz AT, Ruthazer R, Pereira BJ, Levey AS: Level of renal function at the initiation of dialysis in the US end-stage renal disease population. Kidney Int 1999;56:2227–2235.
118.
Smulders YM, Jager A, Gerritsen J, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CDA: Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasian subjects with impaired glucose tolerance or type 2 diabetes. Diabetes Care 2000;23:1369–1374.
119.
Doumas BT, Peters TJ: Serum and urine albumin: A progress report on their measurement and clinical significance. Clin Chim Acta 1997;258:3–20.
120.
Van Acker BA, Koomen GC, Koopman MG, Krediet RT, Arisz L: Discrepancy between circadian rhythms of inulin and creatinine clearance. J Lab Clin Med 1992;120:400–410.
121.
Hilbrands LB, Artz MA, Wetzels JF, Koene RA: Cimetidine improves the reliability of creatinine as a marker of glomerular filtration. Kidney Int 1991;40:1171–1176.
122.
Choi KC, Lee J, Kim SW, Kim NH, Moon KH, Park KK, Bom HS, Kang YJ: Cimetidine improves the accuracy of creatinine clearance as an indicator for glomerular filtration rate. Korean J Intern Med 1993;8:28–33.
123.
Olsen NV, Ladefoged SD, Feldt-Rasmussen B, Fogh-Andersen N, Jordening H, Munck O: The effects of cimetidine on creatinine excretion, glomerular filtration rate and tubular function in renal transplant recipients. Scand J Clin Lab Invest 1989;49:155–159.
124.
Zaltzman JS, Whiteside C, Cattran DC, Lopez FM, Logan AG: Accurate measurement of impaired glomerular filtration using single-dose oral cimetidine. Am J Kidney Dis 1996;27:504–511.
125.
Hirata-Dulas CAI, Halstenson CE, Kasiske BL: Improvement in the accuracy and precision of creatinine clearance as a measure of glomerular filtration rate with oral cimetidine in renal transplant patients. Clin Transplant 1993;7:552–558.
126.
Marcen R, Serrano P, Teruel JL, Rivera ME, Mitjavila M, Navarro J, Orofino L, Sabater J, Ortuno J: Oral cimetidine improves the accuracy of creatinine clearance in transplant patients on cyclosporine. Transplant Proc 1994;26:2624–2625.
127.
Mitch WE, Walser M, Buffington GA, Lemann JJ: A simple method of estimating progression of chronic renal failure. Lancet 1976;ii:1326–1328.
128.
Tougaard L, Brochner-Mortensen J: An individual nomogram for determination of glomerular filtration rate from plasma creatinine. Scand J Clin Lab Invest 1976;36:395–397.
129.
Viberti GC, Bilous RW, Mackintosh D, Keen H: Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med 1983;74:256–264.
130.
Walser M, Drew HH, LaFrance ND: Reciprocal creatinine slopes often give erroneous estimates of progression of chronic renal failure. Kidney Int 1989;27:S81–S85.
131.
Levey AS, Berg RL, Gassman JJ, Hall PM, Walker WG: Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int 1989;27:S73–S80.
132.
Mitch WE, Walser M: A proposed mechanism for reduced creatinine excretion in severe chronic renal failure. Nephron 1978;21:248–254.
133.
Nielsen S, Rehling M, Schmitz A, Mogensen CE: Validity of rapid estimation of glomerular filtration rate in type 2 diabetic patients with normal renal function. Nephrol Dial Transplant 1999;14:615–619.
134.
Kemperman FA, Silberbusch J, Slaats EH, Prins AM, Krediet RT, Arisz L: Follow-up of GFR estimated from plasma creatinine after cimetidine administration in patients with diabetes mellitus type 2. Clin Nephrol 2000;54:255–260.
135.
Broekroelofs J, Stegeman CA, Navis GJ, de Haan J, van der Bij W, de Boer WJ, de Zeeuw D, de Jong PE: Creatinine-based estimation of rate of long term renal function loss in lung transplant recipients. Which method is preferable? J Heart Lung Transplant 2000;19:256–262.
136.
Couchoud C, Pozet N, Labeeuw M, Pouteil-Noble C: Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int 1999;55:1878–1884.
137.
Idink-Mecking CAM, Kolsters G, van Ballegooie E, Bilo HJG: Renal function assessment techniques and protein intake in insulin-dependent diabetic subjects; in Bilo HJG, Idink-Mecking CAM, Miedema K (eds): Creatinine and Renal Function. Zwolle, de Weezenlanden, 1994, pp 91–104.
138.
Zietse R, Blankestijn PJ, Pos B, Balk AH, Derkx FH, Weimar W, Schalekamp MA: Optimising glomerular filtration rate and effective renal plasma flow measurements using a simple pharmacokinetic model. Clin Nephrol 1995;43:29–34.
139.
Ando Y, Hasegawa Y: Prediction equation for glomerular filtration rate. Ann Intern Med 1999;131:629–630.
140.
Donker AJ, van der Hem GK, Sluiter WJ, Beekhuis H: A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 1977;20:97–103.
141.
Apperloo AJ, de Zeeuw D, Donker AJ, de Jong PE: Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. J Am Soc Nephrol 1996;7:567–572.
142.
Wesson LG: Electrolyte excretion in relation to diurnal cycles of renal function. Medicine 1964;43:547–592.
143.
Van Acker BA, Koomen GC, Arisz L: Drawbacks of the constant-infusion technique for measurement of renal function. Am J Physiol 1995;268:F543–F552.
144.
Perrone RD, Steinman TI, Beck GJ, Skibinski CI, Royal HD, Lawlor M, Hunsicker LG: Utility of radioisotopic filtration markers in chronic renal insufficiency: Simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis 1990;16:224–235.
145.
Wetzels JF, Huysmans FT, Koene RA: Creatinine as a marker of glomerular filtration rate. Neth J Med 1988;33:144–153.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
